Currently out of the existing stock ratings of Kalpit Patel, 52 are a BUY (78.79%), 14 are a HOLD (21.21%).

Kalpit Patel

Work Performance Price Targets & Ratings Chart

Analyst Kalpit Patel works with a stock forecast success ratio of 29.71% fulfilled within 124.53 days on average. Previously, Kalpit Patel worked at B.RILEY.

Kalpit Patel’s has documented 131 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on LBPH, Longboard Pharmaceuticals at 12-Jan-2024.

Wall Street Analyst Kalpit Patel

Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/2/2023. The price target of $16 was fulfilled within 5 days with a profit of $3.92 (32.45%) receiving and performance score of 64.9.

Average potential price target upside

BCYC Bicycle Therapeutics Ltd INFI Infinity Pharmaceuticals INKT Mink Therapeutics KYMR Kymera Therapeutics MGTA Magenta Therapeutics RIGL Rigel Pharmaceuticals FBRX Forte Biosciences ALLO Allogene Therapeutics ENTX Entera Bio Ltd INAB In8bio  VINC Vincerx Pharma MRTX Mirati Ther DERM Journey Medical Corp GERN Geron VRDN Viridian Therapeutics SNDX Syndax Pharmaceuticals LBPH Longboard Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

43

$20.43 (90.52%)

43

2 months 3 days ago

0/11 (0%)

$19.8 (85.34%)

Buy

55

$32.43 (143.69%)

57

2 months 3 days ago

1/7 (14.29%)

$31.8 (137.07%)

83

Buy

32

$9.43 (41.78%)

44

4 months 4 days ago

1/9 (11.11%)

$13.92 (76.99%)

174

Buy

65

$42.43 (187.99%)

65

5 months 16 days ago

0/5 (0%)

$49.66 (323.73%)

40

$17.43 (77.23%)

42

5 months 21 days ago

0/5 (0%)

$24.47 (157.57%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Kalpit Patel is most bullish on?

Potential upside of $14.7 has been obtained for VRDN (VIRIDIAN THERAPEUTICS)

Which stock is Kalpit Patel is most reserved on?

Potential downside of -$18.35 has been obtained for KYMR (KYMERA THERAPEUTICS)

What Year was the first public recommendation made by Kalpit Patel?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?